by EmVenio | Aug 20, 2024 | Webinar
Discover an informative webinar that revolutionizes the impact of hybrid clinical trials by implementing patient-centric solutions that fast-track the development of life-changing therapies. Historically, trials necessitated in-person participation,...
by EmVenio | Aug 14, 2024 | Blog
The United States Food and Drug Administration has issued several guidances throughout the last five years to enhance the diversity, equity, and inclusivity of clinical trials. These are significant and much-needed additions to the industry, supporting EmVenio’s...
by EmVenio | Aug 1, 2024 | Press Release
Pre-study visits now available for clinical research organizations and trial sponsors DURHAM, N.C., Aug. 1, 2024 /PRNewswire/ — EmVenio Research announced today it has opened two dedicated research centers within the Prime Healthcare hospital...
by EmVenio | Jul 23, 2024 | Press Release
Denver, CO., July 23, 2024 – PCM Trials and EmVenio Research, a PCM Trials Company are pleased to announce the addition of Jeff Huntsman to the leadership team as Chief Commercial Officer. Jeff brings over 30 years of experience in commercial planning, global business...
by EmVenio | Jun 6, 2024 | Blog
June 6th, 2024 – The Society for Clinical Research Sites (SCRS) proudly announces the addition of EmVenio Research to its Global Impact Partner (GIP) Program. EmVenio, a PCM Trials company, is part of the largest independent decentralized clinical trial (DCT) site...
